BOCH
HELP

Blue Owl Capital Holdings’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Blue Owl Capital Holdings’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$396K Buy
+59,911
New +$300K 0.06% 39

Other funds holding HELP

VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return

Blue Owl Capital Holdings's HELP Position: Q2 2026 in Review

Blue Owl Capital Holdings opened a new position in Helus Pharma Inc. Common Stock (HELP) in Q2 2026: 59,911 shares worth $396K. The stake represents 0.06% of the portfolio and ranks #39 among its holdings.

99 funds tracked by Wall St. Rank hold HELP as of Q2 2026.

  • Blue Owl Capital Holdings held 59,911 shares of Helus Pharma Inc. Common Stock worth $396K as of Q2 2026.
  • Helus Pharma Inc. Common Stock was a new Blue Owl Capital Holdings position in Q2 2026.
  • Helus Pharma Inc. Common Stock made up 0.06% of Blue Owl Capital Holdings's portfolio in Q2 2026, its #39 holding.
  • 99 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q2 2026.

Based on Blue Owl Capital Holdings's 13F filing for Q2 2026, filed 11 Aug 2026.